We also report the initial results of nanostring gene expression profile changes associated with Ad-p53 treatment in a HNSCC patient with a dramatic response to combined Ad-p53 and immune checkpoint inhibitor blockade. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.